By Clinical Research Team   

August 28, 2024 | myTomorrows and Pancreatic Cancer Europe have announced a new partnership to equip patients, caregivers, and healthcare professionals with up-to-date, accessible information about pre-approval treatments that may be relevant to them; the National Institutes of Health has awarded the Ohio State University a $4.38 million grant to support newly trained clinician-scientists for careers in medical research; and more. 

myTomorrows and Pancreatic Cancer Europe (PCE) have announced a new partnership. With this partnership, PCE will use myTomorrows’ vast database of ongoing clinical trials to equip patients, caregivers, and healthcare professionals with up-to-date, accessible information about pre-approval treatments that may be relevant to them. For pancreatic cancer patients, their loved ones, and the Health Care Professionals (HPCs) who treat them, the partnership will ease the process of identifying and understanding the existing clinical trial options. In doing so, it will enable them to make the best possible decisions about their treatment, with myTomorrows’ expert patient navigators demystifying the complexities of clinical trials and supporting patients and their families throughout the process. Press release. 

The National Institutes of Health has awarded the Ohio State University a $4.38 million grant to support newly trained clinician-scientists for careers in medical research. The 5-year award will fund the Clinical and Translational Science Institute K12 program, a mentored research and education program that provides research funding, salary support, and training in clinical and translational science. The K12 program creates opportunities for up-and-coming researchers to develop under the mentorship of experienced researchers.  Press release. 

Veridix AI, part of Emmes Group, launched their new protocol digitization capabilities. This advanced capability lays the foundation to accelerate the clinical trial study build process by up to 30%. Built within Veridix AI's unified eClinical platform, Advantage eClinical Cloud, this new approach utilizes natural language processing (NLP) techniques in combination with AI, to digitize clinical trial protocols into structured data elements such as visit schedules, cohorts, and eCRFs. Press release. 

Clinigen has acquired Kinesys Consulting. This acquisition marks the latest milestone in Clinigen’s strategic growth journey and evolution towards becoming a premier global provider of comprehensive high-value services to the pharmaceutical and biotechnology sectors. This follows the acquisitions of Ascenian Consulting and Drug Safety Navigator. Kinesys adds valuable expertise in regulatory strategy and execution for drugs and medical devices, which complements Clinigen’s capabilities in regulatory affairs, clinical trial services, medical information, and more, allowing Clinigen to offer clients an efficient path to market with enhanced development solutions. Press release. 

Baylor Genetics and the Department of Molecular and Human Genetics at Baylor College of Medicine (BCM) have entered a lab agreement focusing on innovation and high-risk projects that have potentially great clinical impact. This latest collaboration allows for the translation of cutting-edge research into clinical diagnostics, benefiting from BCM’s academic and medical expertise and the clinical diagnostic expertise of Baylor Genetics, in anticipation of larger scale launch when commercially feasible. The new lab, the Medical Genetics Multi-Omics Laboratory, launched its first clinical test, Whole Transcriptomic RNA Sequencing, which is offered by Baylor Genetics to the Undiagnosed Diseases Network and their affiliated institutions. Press release. 

HCLTech announced the launch of an advanced clinical trials and diagnosis solution in collaboration with Denodo and Amazon Web Services (AWS) ecosystem solutions to accelerate the pace of diagnosis and treatment research. This clinical trials and diagnosis solution helps pharmaceutical companies capture comprehensive data insights from the clinical studies, streamlining clinical trials and enabling quicker and better decision-making. The solution enables healthcare providers to efficiently compare new treatments against standard ones, considering varied dosages and demographic impacts through a centralized data model that is secure with real-time access to critical data. Press release.